News | Radiation Therapy | February 07, 2017

First U.K. Hospital Applies Dolphin Quality Assurance System for Radiation Therapy

Northern Ireland cancer center will now be able to perform fully independent, measurement-based quality assurance for IMRT and VMAT treatments

IBA, Dolphin Online Ready Patient QA and Monitoring solution, radiotherapy, North West Cancer Centre, Londonderry, Northern Ireland, first in U.K.

February 7, 2017 — IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its Dolphin Online Ready Patient QA and Monitoring solution in the United Kingdom.

With the use of Dolphin attached to the hospital’s TrueBeam treatment machine, the team at the North West Cancer Centre in Londonderry, Northern Ireland, set a new standard for high quality cancer therapy and a more efficient patient quality assurance (QA) process.

“With Dolphin we can perform fully independent, measurement-based quality assurance of our most advanced IMRT [intensity modulated radiation therapy] and VMAT [volumetric arc therapy] treatments quickly and confidently.” said Andrew Reilly, M.D., head of radiotherapy physics at the North West Cancer Centre, Londonderry. He continued, “Being so straightforward to use, it allows us to plan to the capabilities of the treatment machines, rather than limiting what we do because legacy verification processes cannot keep up. This ensures our clinicians can offer the best possible care to their patients.”

Wendy Hyland, M.D., radiotherapy physicist added, “The measurement process is so easy I can spend more time thinking about what the results mean rather than worrying about the measurements themselves.”

Dolphin is a complete solution that offers a higher capability to detect and verify possible treatment dose discrepancies compared to conventional QA solutions, according to IBA, thus contributing to a more efficient and safer radiation therapy. This improvement is based on Dolphin’s significantly higher treatment dose measurement resolution.

Highly complex IMRT and rotational treatment plans are delivered and measured with the Dolphin transmission detector prior to each patient treatment. A sophisticated TPS-Class software allows verification of dose deviations in 3-D patient anatomy between the plan and actual delivered dose measured with Dolphin.

The hospital’s patient QA workflow efficiency is increased with Dolphin’s “plug and play” wireless setup and its automatic verification software displaying instant QA results.

The Dolphin solution including the detector and the software is online-ready and currently used for pre-treatment QA. The system will be capable of measuring the actual patient treatment dose in online mode, fraction by fraction. The online capability is currently pending release.

For more information: www.iba-dosimetry.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...